Did the FDA approve the Eli Lilly lung cancer drug Alimta for maintenance treatment for patients?
The FDA has approved Alimta, manufactured by Eli Lilly, to essentially become the first maintenance treatment for patients with advanced non-small-cell lung cancer. According to the American Cancer Society, non-small-cell lung cancer is the leading cause of lung cancer deaths in the nation. Typically, advanced (or metastatic) lung cancer patients are given 4-6 rounds of chemotherapy, which is stopped in those patients whose tumors have either stopped growing or are shrinking. The new FDA go ahead means that doctors can continue administering Alimta after the initial round of chemo. In the past, physicians waited to administer the drug until patient tumors began to grow again. Sources: http://www.foodconsumer.org/newsite/Non-food/Drug/070720090655_fda_gives_go_ahead_to_eli_lilly_drug_alimta.
Related Questions
- How do I establish my need for Future Drug Treatment or Methadone maintenance for continued dependency on OxyContin or Oxycodone?
- Did the FDA approve the Eli Lilly lung cancer drug Alimta for maintenance treatment for patients?
- What does the FDA have to say about Eli Lilly lung cancer treatment? Explain?
